Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

NCT04271436 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Low accrual

Conditions

Cancer

Interventions

DEVICE: FDG PET/CT
DEVICE: FLT PET/CT
DEVICE: PET/MR
DRUG: [F-18] flurothymidine

Sponsor

Washington University School of Medicine